BioCentury
ARTICLE | Distillery Therapeutics

Cancer

August 16, 2017 6:00 PM UTC

In vitro, cell culture and mouse studies identified a PLK1 inhibitor that could help treat KRAS-driven colorectal and pancreatic cancers. Screening of a library of 120,000 drug-like molecules an in vi...